Our antibody, ATN001, is the first-in-class PD-(L)1 Sensitizer that can reprogram TME and overcome the limitation of current immuno-oncology drugs.

An epigenome editing platform technology that delivers precise and tunable control of target gene activity for precision medicine

PromentalHealth: Development of a blood test for the diagnosis and personalized treatment of Alzheimer´s Disease. Development of a prognostic blood test for Alzheimer´s Disease.

QTX is an early-stage biotech startup developing innovative regulators of the complement system.

RNhale is a biotech formulating RNA into inhalable dry powder for the next generation of inhalable gene therapeutics.

Great therapies and drugs are truly great if they are delivered properly. We’re developing cutting-edge Direct-to-Cell Delivery Solutions for Biomolecule Delivery.

cureVision revolutionizes analysis & diagnosis & treatment of chronic wounds with AI to enhance healthcare efficiency and reduce documentation time by 90%.

Genome Biologics is a Biotech company with the single focus to improve the lives of patients with cardiovascular disease.

SeaBeLife develops First-In-Class drugs to block cellular necrosis, protecting and regenerating major organs affected by severe pathologies.

SurvivX is a pre-clinical start-up biotech company developing a novel immunomodulatory adjuvant therapy for sepsis.